CDH2 and glioma: We selected N-cadherin, a mesenchymal-type marker that is sensitive to 7 in U87 cells in vitro (Figure 3F), and glial fibrillary acidic protein (GFAP), which plays an important regulatory role in glioma cell motility (Uceda-Castro et al., 2022), as markers of interest.